Perbedaan Multifiling Mitra Indonesia Tbk. dan Charlie Hospital Semarang Tbk.: Multifiling Mitra Indonesia Tbk. diperdagangkan di Rp1.300 (kapitalisasi pasar 984,86 M), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp430 (kapitalisasi pasar 1,11 T, volume 24 jam 25,61 jt). Perbedaan utamanya: Multifiling Mitra Indonesia Tbk. dan Charlie Hospital Semarang Tbk. berukuran mirip dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| MFMI | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 984,86 M | 1,11 T |
Volume | — | 25,61 jt |
Lot | — | 256,07 rb |
Perputaran | — | 10,76 M |
Harga Rata-rata | — | 420,16 |
Nilai Transaksi | — | 10,76 M |
Harga Ekuilibrium Indikatif | — | 430 |
Volume Ekuilibrium Indikatif | — | 1,46 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Multifiling Mitra Indonesia Tbk (the Company) was established based on the Notarial Deed No. 157 of Misahardi Wilamarta, SH., dated July 9, 1992. MMI is a joint venture company between PT.Multipolar Corp. Tbk. and PT. Lippo Karawaci Tbk, currently serving its customers in 4-big city, Jakarta, Surabaya, Medan dan Bandung.
Selengkapnya di halaman MFMI →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →